Your support can directly benefit health and well being research - from tackling infectious diseases and researching new therapies for neurological conditions - the choice is yours.
Our medical research has benefitted millions of individuals and you can help too by fundraising in aid of the cause close to your heart. Below are just a few examples of the areas you can help. If there is an area you are interested in helping that isn’t listed below, please get in touch to discuss.
Anne Rowling Regenerative Neurology Clinic
Research at the Anne Rowling Clinic is discovering new information, delivering drug trials, and improving quality of life for people living with MS, MND and other neurodegenerative conditions. The unique welcoming environment of our Clinic aims to help people attending NHS out-patient and research appointments to feel comfortable and relaxed during their visit.
As well as delivering excellent clinical care, we are conducting world-class research to improve the lives of people with degenerative conditions affecting the brain including multiple sclerosis (MS), motor neurone disease (MND), Parkinson's disease, and early-onset dementias.
By combining clinical care and scientific research we are giving people living with neurodegenerative conditions the opportunity to take part in research studies and be part of innovations and discoveries that will have a positive impact for the future.
Edinburgh Cancer Research Centre
It is estimated that more than one in three people will develop some form of cancer during their lifetime. Support the University of Edinburgh and choose exactly what area of research you want your money to support.
Our Cancer Research Centre brings together cancer scientists and clinicians from across the University of Edinburgh, delivering outstanding cancer research and improved patient care. By supporting cancer research through the University of Edinburgh, you can choose exactly what area of research you want your money to support.
Centre for Dementia Prevention
The University of Edinburgh’s Centre for Dementia Prevention combines research in science, medicine and social sciences to lead global efforts in preventing dementia.
Over 50 million people are living with dementia worldwide. Dementia can rob people of their memories, independence and dignity. Current drug treatments are only minimally effective and do not directly target the underlying disease or stop memory and thinking decline. With your support, we believe it will soon be possible to prevent dementia before it begins.
At the Centre for Dementia Prevention, we seek to empower people to understand and protect their brain health, for a future without dementia.
Cystic Fibrosis Gene Therapy Research
Cystic fibrosis is a life-threatening hereditary disease that affects the lungs and digestive system. Those born with cystic fibrosis today have a life expectancy of around forty years, thanks to the success of existing treatments which alleviate the symptoms of the disease. However, to make significant improvements to the quality of life and extend its duration, it is believed that new therapies targeting the root cause of the disease must be developed.
Cystic fibrosis gene therapy research in Edinburgh is carried out by groups of scientists and clinicians who aim to translate scientific advances in gene therapy into practical treatments for people with cystic fibrosis.
Euan MacDonald Centre for MND Research
Pioneering research at the Euan MacDonald Centre is finding out vital new information about motor neurons, working towards new drug treatments and improving quality of life for people with motor neurone disease (MND).
Motor neurons are cells that transmit electrical messages to tell your muscles what to do. MND gradually stops these messages reaching the muscles, leading to muscle weakness, loss of mobility and difficulties speaking, swallowing and breathing.
The Euan MacDonald Centre, based at the University of Edinburgh, is a network of over 200 researchers across Scotland. We use research to improve the lives of people living with MND and related conditions.
Excellence in Pelvic Pain and Endometriosis Care and Treatment (EXPPECT)
Endometriosis affects an estimated 176 million women. It occurs when tissue similar to the lining of the uterus is found elsewhere - most commonly in the abdomen, on the ovaries, bladder and bowel.
This misplaced tissue behaves like the lining of the uterus, bleeding every month and creating local inflammation. It is associated with chronic pain, heavy bleeding, and infertility, and can impact on mental, and social wellbeing.
There is no cure for women with pelvic pain and endometriosis, and there is an unmet need for better treatments.
The EXPPECT team in Edinburgh aims to provide high quality, evidence-based and patient-centred management of pelvic pain and carries out pioneering endometriosis research.
EXPPECT (external website)
Functional Neurological Disorder (FND) Research
Functional disorders are one of the commonest reasons for patients to see a neurologist. They include problems such as dissociative (non-epileptic) seizures, functional movement disorders (such as tremors, spasms or jerks) and functional limb weakness. Functional Neurological Disorders (sometimes abbreviated to FND) are genuine and often disabling. They relate to a disorder of nervous system functioning but not brain disease. Other terms used to describe these hidden and stigmatised disorders include conversion disorder and psychogenic disorders.
The Edinburgh team carries out clinical research on a wide range of functional disorders, looking at how common they are, why and how they happen and trialling physical and psychological treatments.
Institute for Regeneration and Repair
Research taking place at the Institute for Regeneration and Repair aims to transform how we treat major diseases in the future, including: cancer, heart and lung disease, liver failure, diabetes, (multiple sclerosis) MS and Parkinson's.
If you go to your GP with an illness today, you will be given a treatment that is designed to stop any further damage happening. However, you won’t be given a treatment that’s actually designed to enhance the repair of the body, to repair the damage that’s already been done.
Scientists and clinicians based at the Institute aim to change this. They seek to understand stem cell biology, inflammation and disease to develop new treatments to help heal damaged tissues (regenerative treatments), ultimately making these available to patients in the clinic.
If this were to be achieved, it would be truly transformational. Your support can help make this happen.
Labrune Syndrome, also known as LCC (Leukoencephalopathy, Calcification and Cysts), is a rare degenerative brain disease that severely affects the brain. Most of those affected are children and young adults, who can suffer from an array of neurological symptoms including seizures and progressive loss of speech, function and mobility.
Professor Crow and his research team at the University of Edinburgh are working to understand the causes of this devastating disease and identify urgently needed treatments.
Muir Maxwell Epilepsy Centre
There are over 600,000 people with epilepsy in the UK. We aim to revolutionise research and clinical care in epilepsy on an unprecedented scale in the UK and beyond. We welcome interdisciplinary collaboration to address the many aspects of epilepsy.
Epilepsy is a complex condition that not only affects the person living with epilepsy, but also impacts on their family’s lives too. Currently, in 70% of cases, the cause of epilepsy is unknown and 30% of children don’t respond to current treatment options. A substantial number of patients’ symptoms are not limited to just seizures. There is a vital need for research into this common neurology condition.
Our mission is to develop the very best treatments for those children and families affected by the condition by fostering collaborations between world-class scientists and clinical researchers at the University of Edinburgh and beyond.
National CJD Research & Surveillance Unit
Creutzfeldt-Jakob Disease (CJD) is a rare illness and is one of a group of diseases called prion diseases, which affect humans and animals. Prion diseases exist in different forms, all of which are progressive, currently untreatable and ultimately fatal.
The National CJD Research & Surveillance Unit aims to monitor the characteristics of all forms of CJD, to identify trends in incidence rates, to study risk factors for the development of disease and to contribute to improving the quality of care for those with CJD. Based at the Western General Hospital in Edinburgh, the Unit brings together a team of clinical neurologists, neuropathologists, scientists and others.
Ophthalmology research is an active and ongoing programme at the University. One exciting and emerging research theme will focus on Late Onset Retinal Macular Degeneration (LORD). Inherited retinal disease is the most common cause of registerable blindness in the developed world and is a good model for understanding age-related macular degeneration (AMD). Loss of vision poses a major challenge for people with LORD or AMD and has a profound effect on lifestyle and employment opportunities.
Professor Baljean Dhillon, NES Chair of Clinical Ophthalmology, at the Centre for Clinical Brain Sciences, is leading vital ophthalmology research.
Patrick Wild Centre for Research into Autism, Fragile X Syndrome and Intellectual Disabilities
Autism spectrum disorder and intellectual disability affect around three per cent of the UK population. For those affected and their loved ones, greater understanding and better treatments cannot come soon enough.
The Patrick Wild Centre brings together experts in laboratory research and clinical practice. Colleagues are working collaboratively to better understand the causes of - and to test new therapies for – these complex conditions, putting patients and families at the heart of their scientific endeavour.
Alongside its research effort, an important part of the Centre’s work is to raise public awareness and understanding of autism spectrum disorders, fragile X syndrome and intellectual disabilities.
Research to Understand Stroke due to Haemorrhage (RUSH)
The deadliest type of stroke is caused by spontaneous bleeding from blood vessels into the brain, known as intracerebral haemorrhage (or brain haemorrhage). Each year this disease affects about 10,000 adults in the UK and around two million adults worldwide.
Our Research to Understand Stroke due to Haemorrhage (RUSH) programme is dedicated to better understanding the causes and outcome of spontaneous (non-traumatic) intracerebral haemorrhage in adults, leading to randomised controlled clinical trials of interventions to improve patient outcome.
You can support any area of the University. The above is just an example of the different areas of lifesaving research we are currently involved in. Please don't hesitate to get in touch to discuss other areas of research that would benefit from your support. Thank you.